| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000020511 |
| Receipt No. | R000023416 |
| Official scientific title of the study | Analysis of the high-order aberrations and tear film lipid layer thickness in the eye of epiphora patients |
| Date of disclosure of the study information | 2016/01/20 |
| Last modified on | 2018/04/11 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Analysis of the high-order aberrations and tear film lipid layer thickness in the eye of epiphora patients | |
| Title of the study (Brief title) | Analysis of the high-order aberrations and tear film lipid layer thickness | |
| Region |
|
|
| Condition | ||
| Condition | Epiphora | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Analysis of the high-order aberrations and tear film lipid layer thickness in the eye of epiphora patients |
| Basic objectives2 | Others |
| Basic objectives -Others | comparison between pre and post-operative measure of the high-order aberrations and tear film lipid layer thickness |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | the high-order aberrations and tear film lipid layer thickness |
| Key secondary outcomes | pre and post-operative measure of the high-order aberrations and tear film lipid layer thickness |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.the patient who was diagnosed to have lacrimal disorder
2.the patient who were diagnosed not to have lacrimal disorder 3.the patient whose age is 20 years old or older at the time of enrollment |
|||
| Key exclusion criteria | 1.the minor or patient who disagree to participate in this study
2.the patient whose corrected visual acuity is less than 0.4 3.the eye with narrow angle 4.the patient who have apparent kerato-conjunctival disease 5.the patient who have eyelid disease such as entropion and ectropion 6.the patient who have trichiasis 7.the patient who was determined to be difficult of undergoing examinations in this study |
|||
| Target sample size | 65 | |||
| Research contact person | |
| Name of lead principal investigator | Takanori Mizoguchi |
| Organization | Mizoguchi Eye Clinic |
| Division name | department of ophthalmology |
| Address | 6-13 Tawaramachi, Sasebo, Nagasaki 857-0016, Japan |
| TEL | 0956-22-5681 |
| t-mizo@siren.ocn.ne.jp | |
| Public contact | |
| Name of contact person | Masahiro Fujimoto |
| Organization | Kyoto University Graduate School of Medicine |
| Division name | Department of Ophthalmology and Visual Schiences |
| Address | 54 S hogoin Kawaharacho, Sakyo-ku, Kyoto 606-8507 |
| TEL | 075-751-3111 |
| Homepage URL | |
| m2fjmt@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Mizoguchi Eye Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Mizoguchi Eye Clinic |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 溝口眼科(長崎県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Study design: case-control study
Rectuiting method of the responders: all patients which visit mizoguchi eye clinic from February 2016 to January 2017 and match the selection criteria Measurement item: The following noninvasive examinations are underwent. 1. functional visual acuity testing 2. wavefront analysis of higher-order aberrations 3. measurement of tear meniscus height 4. measurement of tear film lipid layer depth 5. measurement of meibomian gland morphology |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023416 |